Thompson Davis & Co’s Thermo Fisher Scientific TMO Stock Holding History

Thompson Davis & Co’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-106	Closed	-$20K	–	1054
2017 Q3	$20K	Sell	106 -7	-6%	-$1.27K	0.04%	486
2017 Q2	$20K	Sell	113 -5	-4%	-$840	0.03%	469
2017 Q1	$18K	Buy	118 +105	+808%	+$16K	0.03%	535
2016 Q4	$2K	Sell	13 -80	-86%	-$11.8K	﹤0.01%	1038
2016 Q3	$15K	Sell	93 -316	-77%	-$48.7K	0.03%	562
2016 Q2	$60K	Buy	409 +279	+215%	+$41.2K	0.1%	209
2016 Q1	$18K	Buy	+130	New	+$17.4K	0.03%	500
2015 Q4	–	Sell	-85	Closed	-$10K	–	1189
2015 Q3	$10K	Buy	85 +43	+102%	+$5.6K	0.01%	655
2015 Q2	$5K	Buy	+42	New	+$5.47K	0.01%	915
2014 Q4	–	Sell	-1,130	Closed	-$138K	–	1256
2014 Q3	$138K	Buy	+1,130	New	+$137K	0.18%	121
2014 Q2	–	Sell	-972	Closed	-$117K	–	851
2014 Q1	$117K	Buy	+972	New	+$116K	0.19%	137

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thompson Davis & Co's TMO Position: Q4 2017 in Review

Thompson Davis & Co sold out of Thermo Fisher Scientific (TMO) in Q4 2017, closing a stake of 106 shares — an estimated $20K sold.

Thompson Davis & Co first reported a position in TMO in Q1 2014 and held it in 11 quarters. The position peaked at $138K in Q3 2014. 1,246 funds tracked by Wall St. Rank hold TMO as of Q4 2017.

Thompson Davis & Co reported no remaining Thermo Fisher Scientific position as of Q4 2017 after selling out during the quarter.
Thompson Davis & Co sold 106 Thermo Fisher Scientific shares in Q4 2017, an estimated $20K.
Thompson Davis & Co first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 11 quarters.
Thompson Davis & Co's Thermo Fisher Scientific position peaked at $138K in Q3 2014.
1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.